Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Lymphoma, T-Cell, Peripheral × romidepsin × Clear all

Phase

Status

Sponsor Class

OTHER 10 INDUSTRY 4 NIH 2 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Melanoma 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Large B-Cell, Diffuse 1

Interventions

romidepsin 1 imetelstat 1 Polymerase Chain Reaction 1 Gemcitabine 1 Dexamethasone 1 Cytogenetic Analysis 1 Cisplatin 1 Chromosome Mapping 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01846390 2023-08-04

Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma

Canadian Cancer Trials Group

Phase 1 Completed

Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡